Clinical Trials Directory

Trials / Completed

CompletedNCT00148278

Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock

Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
330 (actual)
Sponsor
University of Versailles · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Catecholamines infusion is a major component of septic shock management. International guidelines recommend that norepinephrine should be preferred to epinephrine, though phase III trials are lacking. The present study aimed at comparing the efficacy and safety of norepinephrine plus dobutamine to that of epinephrine in adults with septic shock.

Detailed description

The french Conference on Consensus on catecholamines use in septic shock has underlined the importance of carrying out a clinical trial to clarify the use of epinephrine, norepinephrine and dobutamine in the management of multiple organ failure associated with severe sepsis. The main objective of the study was therefore to compare the effects of the combination of dobutamine and norepinephrine to those of epinephrine alone in patients with septic shock. In this purpose, patients were randomly assigned to receive either epinephrine or norepinephrine plus dobutamine and drugs were titrated to maintain blood pressure over 70 mmHg. Main outcome was 28-day mortality.

Conditions

Interventions

TypeNameDescription
DRUGnorepinephrine and dobutaminecontinuous infusion of norepinephrine titrated to maintain a mean arterial pressure at 70mmHg or more and dobutamine could be added as a continuous infusion when cardiac index was of less than 2.5 liters per squared meter of body surface
DRUGepinephrine plus placebo of dobutamineepinephrine was titrated to maintain a mean arterial pressure at 70mmHg or more and placebo of dobutamine was titrated in case of a cardiac index lower than 2.5 liters per squared meters of body surface

Timeline

Start date
1999-10-01
Primary completion
2004-12-01
Completion
2005-12-01
First posted
2005-09-07
Last updated
2010-07-22

Locations

15 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00148278. Inclusion in this directory is not an endorsement.